Sowell Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $796K | Sell |
47,508
-2,405
| -5% | -$40.3K | 0.03% | 475 |
|
|
2025
Q1 | $767K | Buy |
49,913
+313
| +0.6% | +$4.81K | 0.03% | 471 |
|
|
2024
Q4 | $1.09M | Buy |
49,600
+9,291
| +23% | +$205K | 0.06% | 301 |
|
|
2024
Q3 | $726K | Sell |
40,309
-4,718
| -10% | -$85K | 0.03% | 399 |
|
|
2024
Q2 | $732K | Sell |
45,027
-2,780
| -6% | -$45.2K | 0.04% | 382 |
|
|
2024
Q1 | $675K | Hold |
47,807
| – | – | 0.03% | 410 |
|
|
2023
Q4 | $499K | Sell |
47,807
-200
| -0.4% | -$2.09K | 0.03% | 428 |
|
|
2023
Q3 | $490K | Buy |
48,007
+200
| +0.4% | +$2.04K | 0.03% | 397 |
|
|
2023
Q2 | $360K | Buy |
47,807
+410
| +0.9% | +$3.09K | 0.02% | 494 |
|
|
2023
Q1 | $419K | Sell |
47,397
-440
| -0.9% | -$3.89K | 0.03% | 480 |
|
|
2022
Q4 | $436K | Buy |
47,837
+6,350
| +15% | +$57.9K | 0.03% | 446 |
|
|
2022
Q3 | $335K | Hold |
41,487
| – | – | 0.03% | 358 |
|
|
2022
Q2 | $312K | Buy |
+41,487
| New | +$312K | 0.03% | 250 |
|
|
2022
Q1 | – | Sell |
-36,623
| Closed | -$293K | – | 486 |
|
|
2021
Q4 | $293K | Buy |
36,623
+2,451
| +7% | +$19.6K | 0.02% | 485 |
|
|
2021
Q3 | $333K | Hold |
34,172
| – | – | 0.02% | 441 |
|
|
2021
Q2 | $338K | Buy |
34,172
+504
| +1% | +$4.99K | 0.02% | 462 |
|
|
2021
Q1 | $346K | Buy |
33,668
+32,066
| +2,002% | +$330K | 0.01% | 780 |
|
|
2020
Q4 | $15K | Sell |
1,602
-737
| -32% | -$6.9K | ﹤0.01% | 1865 |
|
|
2020
Q3 | $21K | Buy |
2,339
+264
| +13% | +$2.37K | ﹤0.01% | 1549 |
|
|
2020
Q2 | $26K | Sell |
2,075
-1,440
| -41% | -$18K | ﹤0.01% | 1382 |
|
|
2020
Q1 | $32K | Sell |
3,515
-2,750
| -44% | -$25K | ﹤0.01% | 1221 |
|
|
2019
Q4 | $61K | Buy |
6,265
+1,810
| +41% | +$17.6K | ﹤0.01% | 1085 |
|
|
2019
Q3 | $31K | Buy |
+4,455
| New | +$31K | ﹤0.01% | 1139 |
|